Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study.

Yasutaka YamadaShinichi SakamotoKodai SatoShinpei SaitoManato KanesakaJunryo RiiKoichiro KurokawaDaisuke TachiwakiYudai FukuiHiroki ShibataYusuke GotoTomokazu SazukaYusuke ImamuraHiroomi NakatsuTomohiko Ichikawa

Published in: The Prostate (2023)

A low pretreatment PNI might be an effective biomarker of poor treatment response and survival in patients with mHSPC undergoing ADT.

Keyphrases

prostate cancer
radical prostatectomy
free survival
cross sectional
double blind
clinical trial